Literature DB >> 24016812

Is it necessary to adjust for calendar time in a test negative design?: Responding to: Jackson ML, Nelson JC. The test negative design for estimating influenza vaccine effectiveness. Vaccine 2013;31(April (17)):2165-8.

Peter Jacoby1, Heath Kelly2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24016812     DOI： 10.1016/j.vaccine.2013.08.048

Source DB:  PubMed          Journal:  Vaccine        ISSN： 0264-410X            Impact factor:   3.641


× No keyword cloud information.
  9 in total

1.  RE: "MEASUREMENT OF VACCINE DIRECT EFFECTS UNDER THE TEST-NEGATIVE DESIGN".

Authors:  Natalie E Dean
Journal:  Am J Epidemiol       Date:  2019-04-01       Impact factor: 4.897

Review 2.  Potential of the test-negative design for measuring influenza vaccine effectiveness: a systematic review.

Authors:  Sheena G Sullivan; Shuo Feng; Benjamin J Cowling
Journal:  Expert Rev Vaccines       Date:  2014-10-28       Impact factor: 5.217

3.  Temporal Confounding in the Test-Negative Design.

Authors:  Natalie E Dean; M Elizabeth Halloran; Ira M Longini
Journal:  Am J Epidemiol       Date:  2020-11-02       Impact factor: 4.897

4.  Duration of mRNA vaccine protection against SARS-CoV-2 Omicron BA.1 and BA.2 subvariants in Qatar.

Authors:  Hiam Chemaitelly; Houssein H Ayoub; Sawsan AlMukdad; Peter Coyle; Patrick Tang; Hadi M Yassine; Hebah A Al-Khatib; Maria K Smatti; Mohammad R Hasan; Zaina Al-Kanaani; Einas Al-Kuwari; Andrew Jeremijenko; Anvar Hassan Kaleeckal; Ali Nizar Latif; Riyazuddin Mohammad Shaik; Hanan F Abdul-Rahim; Gheyath K Nasrallah; Mohamed Ghaith Al-Kuwari; Adeel A Butt; Hamad Eid Al-Romaihi; Mohamed H Al-Thani; Abdullatif Al-Khal; Roberto Bertollini; Laith J Abu-Raddad
Journal:  Nat Commun       Date:  2022-06-02       Impact factor: 17.694

5.  Maximum likelihood estimation of influenza vaccine effectiveness against transmission from the household and from the community.

Authors:  Kylie E C Ainslie; Michael J Haber; Ryan E Malosh; Joshua G Petrie; Arnold S Monto
Journal:  Stat Med       Date:  2017-11-28       Impact factor: 2.373

6.  Adjusting for calendar time in a TND influenza study.

Authors:  Jozef J P Nauta
Journal:  Epidemiol Infect       Date:  2016-05-16       Impact factor: 4.434

7.  Estimating influenza vaccine effectiveness using routine surveillance data among children aged 6-59 months for five consecutive influenza seasons.

Authors:  Wei-Ju Su; Ta-Chien Chan; Pei-Hung Chuang; Yu-Lun Liu; Ping-Ing Lee; Ming-Tsan Liu; Jen-Hsiang Chuang
Journal:  Int J Infect Dis       Date:  2014-11-18       Impact factor: 3.623

8.  Effects of Previous Infection and Vaccination on Symptomatic Omicron Infections.

Authors:  Heba N Altarawneh; Hiam Chemaitelly; Houssein H Ayoub; Patrick Tang; Mohammad R Hasan; Hadi M Yassine; Hebah A Al-Khatib; Maria K Smatti; Peter Coyle; Zaina Al-Kanaani; Einas Al-Kuwari; Andrew Jeremijenko; Anvar H Kaleeckal; Ali N Latif; Riyazuddin M Shaik; Hanan F Abdul-Rahim; Gheyath K Nasrallah; Mohamed G Al-Kuwari; Adeel A Butt; Hamad E Al-Romaihi; Mohamed H Al-Thani; Abdullatif Al-Khal; Roberto Bertollini; Laith J Abu-Raddad
Journal:  N Engl J Med       Date:  2022-06-15       Impact factor: 176.079

9.  Detailed Report on 2014/15 Influenza Virus Characteristics, and Estimates on Influenza Virus Vaccine Effectiveness from Austria's Sentinel Physician Surveillance Network.

Authors:  Monika Redlberger-Fritz; Michael Kundi; Theresia Popow-Kraupp
Journal:  PLoS One       Date:  2016-03-14       Impact factor: 3.240
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.